TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Problems

Premenstrual disorders including premenstrual syndrome and premenstrual dysphoric disorder

Key Statistics

  • 3–8% — Women with severe PMS/PMDD
  • 86% — PMDD patients considering suicide
  • 5 of 11 — DSM-5 symptoms needed (≥1 core)

Don't-miss facts

  1. PMDD: ≥5 of 11 DSM-5 symptoms (≥1 core), confirmed by prospective diary over 2 cycles, before treatment starts

  2. PMDD in ICD-11 (2019), code GA34.41 – genitourinary AND depressive disorder cross-listing

  3. 86% of PMDD patients have considered suicide, 30% have attempted – treat all PMD as suicidality risk

  4. No symptom-free interval before ovulation = unlikely PMS/PMDD – consider premenstrual exacerbation of another disorder

  5. Stepwise Rx: lifestyle/CBT/SSRI or COCP → SSRI+COCP or estrogen/progesterone → GnRHa ± add-back HRT → hysterectomy+BSO ± HRT

  6. GnRHa >6 months needs add-back HRT + bone density monitoring; question diagnosis if no relief by 12 weeks

  7. BSO essential with hysterectomy – unopposed estrogen otherwise risks symptom recurrence

  8. Dutasteride 2.5mg/day blocks luteal allopregnanolone rise (2016 RCT) – reduces PMDD symptoms

First-line drug doses

Fluoxetine 20mg/day Sertraline 50–100mg/day Citalopram/Escitalopram 20mg/day Paroxetine 20mg/day

Drospirenone 3mg/EE 20mcg COCP 24/4

Abbreviation Key

  • PMS — premenstrual syndrome
  • DRSP/PRISM — Daily Record of the Severity of the Problem / Prospective Record of the Impact and Severity of Menstrual
  • PMDD — premenstrual dysphoric disorder Symptoms
  • PMD — premenstrual disorder
  • CBT (iCBT) — cognitive behavioural therapy (internet-based)
  • DSM-5 — Diagnostic and Statistical Manual of Mental Disorders, 5th
  • SSRI/SNRI — selective serotonin / serotonin–noradrenaline reuptake edition inhibitor
  • ICD-11 — International Classification of Diseases, 11th revision
  • COCP (UKMEC) — combined oral contraceptive pill (UK Medical
  • ISPMD — International Society for Premenstrual Disorders Eligibility Criteria)
  • NAPS — National Association for Premenstrual Syndromes
  • VTE — venous thromboembolism
  • IAPMD — International Association for Premenstrual Disorders
  • LNG-IUS — levonorgestrel intrauterine system
  • CNS/GABA — central nervous system / gamma-aminobutyric acid
  • HRT — hormone replacement therapy
  • ESR1 — estrogen receptor 1 gene (SNP = single nucleotide polymorphism)
  • GnRH(a) — gonadotrophin-releasing hormone (agonist)
  • BSO — bilateral salpingo-oophorectomy
  • fMRI/MR — functional / magnetic resonance imaging
  • VAC — Vitex agnus castus
  • MAO — monoamine oxidase
  • GAMSA — GABAA modulating steroid antagonist
  • MDT — multidisciplinary team
  • DALYs / USS — disability-adjusted life years / ultrasound scan

Source: Goswami N et al. Premenstrual disorders including premenstrual syndrome and premenstrual dysphoric disorder. The Obstetrician & Gynaecologist 2023;25:38–46. doi:10.1111/tog.12848

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free